Ebumab Sandbox ApS is a Danish APS based in København N, operating in the Manufacture of pharmaceutical preparations sector. Incorporated in 2022, the company reported a gross profit of -DKK 12.6k in its latest annual filing.
Selskabet tegnes af direktionen i forening med bestyrelsesformanden eller af den samlede bestyrelse
Company purpose
Selskabets formål er drive virksomhed indenfor forskning, udvikling og markedsføring af farmaceutiske og medicinske præparater samt anden efter bestyrelsens skøn beslægtet virksomhed.
In its most recent annual report (2025), Ebumab Sandbox ApS reported a gross profit of -DKK 12.6k. The figures on this page draw on 3 annual filings covering 2023 to 2025. The bottom line showed a net loss of DKK 11.2k.
At the end of 2025, equity financed 100% of the balance sheet.
Frequently asked questions
What is the CVR number of Ebumab Sandbox ApS?
Ebumab Sandbox ApS is registered with CVR / Virk under CVR 43575627.
What is the gross profit of Ebumab Sandbox ApS?
Ebumab Sandbox ApS reported a gross profit of -DKK 12.6k in 2025.
Who is the CEO of Ebumab Sandbox ApS?
Hans Heugh Wandall is the CEO of Ebumab Sandbox ApS.
Who is the chairman of Ebumab Sandbox ApS?
Thomas Dal Stenfeldt Batchelor chairs the board of Ebumab Sandbox ApS.
Where is Ebumab Sandbox ApS headquartered?
Ebumab Sandbox ApS's registered address is Ole Maaløes Vej 3.
